Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Shah

Showing results (1-10 of 3,190) with videos related to

Pageof 319
Sort By:
Drug Safety|January 17, 2019
Safety and Tolerability of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in OncologyRashmi R Shah, Devron R Shah
British Journal of Clinical Pharmacology|September 18, 2012
Response to the comments from Drs Shimazawa and IkedaRashmi R Shah, Devron R Shah
British Journal of Clinical Pharmacology|May 18, 2012
Personalized medicine: is it a pharmacogenetic mirage?Rashmi R Shah, Devron R Shah
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 7, 2017
Very-long-term efficacy of bioresorbable vascular scaffoldsR Shah
Archives of Internal Medicine|December 1, 1980
Aspirin as an antiplatelet agentR Shah
Journal of the Kansas Dental Association|July 1, 1991
Advantages and disadvantages to hiring an associate with no contractR Shah
Drug Safety|April 27, 2013
Cardiovascular safety of tyrosine kinase inhibitors: with a special focus on cardiac repolarisation (QT interval)Rashmi R Shah, Joel Morganroth, Devron R Shah
Iowa Medicine : Journal of the Iowa Medical Society|March 1, 1997
Socioeconomic impact of child abuse. It is easier to build strong children than to mend broken menR Shah
Methods and Findings in Experimental and Clinical Pharmacology|January 1, 1996
CPMP note for guidance: clinical trials on the medicinal products in the treatment of cardiac failureR Shah
Child: Care, Health and Development|January 1, 1997
Improving services to Asian families and children with disabilitiesR Shah
Pageof 319

Showing results (1-10 of 3,190) with videos related to

Sort By:
Pageof 319
Drug Safety|January 17, 2019
Safety and Tolerability of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in OncologyRashmi R Shah, Devron R Shah
British Journal of Clinical Pharmacology|September 18, 2012
Response to the comments from Drs Shimazawa and IkedaRashmi R Shah, Devron R Shah
British Journal of Clinical Pharmacology|May 18, 2012
Personalized medicine: is it a pharmacogenetic mirage?Rashmi R Shah, Devron R Shah
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 7, 2017
Very-long-term efficacy of bioresorbable vascular scaffoldsR Shah
Archives of Internal Medicine|December 1, 1980
Aspirin as an antiplatelet agentR Shah
Journal of the Kansas Dental Association|July 1, 1991
Advantages and disadvantages to hiring an associate with no contractR Shah
Drug Safety|April 27, 2013
Cardiovascular safety of tyrosine kinase inhibitors: with a special focus on cardiac repolarisation (QT interval)Rashmi R Shah, Joel Morganroth, Devron R Shah
Iowa Medicine : Journal of the Iowa Medical Society|March 1, 1997
Socioeconomic impact of child abuse. It is easier to build strong children than to mend broken menR Shah
Methods and Findings in Experimental and Clinical Pharmacology|January 1, 1996
CPMP note for guidance: clinical trials on the medicinal products in the treatment of cardiac failureR Shah
Child: Care, Health and Development|January 1, 1997
Improving services to Asian families and children with disabilitiesR Shah
Pageof 319